+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07831213

Observational Study on the Safety and Performance of RefillHA Lips for Mild Lip Defects in Routine Clinical Practice

Led by Glyance · Updated on 2026-09-21

87

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a post-market, prospective, open-label observational study to evaluate the safety and performance of RefillHA Lips for remodeling and correcting mild defects of the lips. This study focuses on adults over 18 years old who are willing to undergo non-surgical aesthetic procedures using RefillHA Lips in routine clinical practice. Participants will receive at least one injection of RefillHA Lips according to routine clinical care, with the injection technique, volume, and follow-up left to the practitioners discretion. Treatments can be for single or multiple indications, with retreatments allowed anytime during the study as needed. The study includes an initial baseline visit followed by scheduled follow-up visits at 1, 3, 6, 9, and 12 months after baseline. Additional visits may occur if requested by the participant or deemed necessary. During the study, participants will be evaluated for safety and performance at each visit through area-specific assessments of the lips. The study measures outcomes up to 56 weeks after treatment, focusing on the products safety and effectiveness in everyday clinical use. Participation involves multiple visits over a year where practitioners will monitor treatment results and any safety concerns.

CONDITIONS

Brief Title

Post-Market Clinical Follow-up (PMCF) Study of Safety and Performance of 300-01 RefillHA Lips

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here